EP0554579A1 - Cathéter avec un support vasculaire - Google Patents

Cathéter avec un support vasculaire Download PDF

Info

Publication number
EP0554579A1
EP0554579A1 EP92200294A EP92200294A EP0554579A1 EP 0554579 A1 EP0554579 A1 EP 0554579A1 EP 92200294 A EP92200294 A EP 92200294A EP 92200294 A EP92200294 A EP 92200294A EP 0554579 A1 EP0554579 A1 EP 0554579A1
Authority
EP
European Patent Office
Prior art keywords
catheter
stent
vessel
vessel support
inner catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP92200294A
Other languages
German (de)
English (en)
Other versions
EP0554579B1 (fr
Inventor
Christian Imbert
Eugen Hofmann
Marc Gianotti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schneider Europe GmbH
Original Assignee
Schneider Europe GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schneider Europe GmbH filed Critical Schneider Europe GmbH
Priority to EP92200294A priority Critical patent/EP0554579B1/fr
Priority to AT92200294T priority patent/ATE135900T1/de
Priority to ES92200294T priority patent/ES2086633T3/es
Priority to DE59205857T priority patent/DE59205857D1/de
Priority to CA2088557A priority patent/CA2088557C/fr
Priority to AU32185/93A priority patent/AU654075B2/en
Priority to RU9393005293A priority patent/RU2055545C1/ru
Priority to JP5016416A priority patent/JP2620028B2/ja
Publication of EP0554579A1 publication Critical patent/EP0554579A1/fr
Priority to US08/433,281 priority patent/US5607466A/en
Application granted granted Critical
Publication of EP0554579B1 publication Critical patent/EP0554579B1/fr
Priority to US08/752,273 priority patent/US5725571A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/962—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve
    • A61F2/966—Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod

Definitions

  • the invention relates to a catheter with a cylindrical stent from a permeable network of intersecting stiff threads, the stent expanding under its own power through its radial elasticity under its own power into a relaxed state supporting the wall of the vessel when used Length of constant large circumference, with a tubular outer catheter shaft, which receives the tensioned stent at its distal end and from which the stent can be released for use, with a displaceable inner catheter inside the tubular outer catheter shaft, which holds the stent on her supports the proximal end axially, the outer catheter shaft being withdrawn with respect to the inner catheter to release the stent.
  • Such catheters are known for example from US 4,655,771. They are used to implant vascular supports, vascular endoprostheses, so-called stents, in vessels of the human body. A particular area of application for these stents has recently emerged in connection with the increased use of percutaneous transluminal coronary recanalization (PTCA).
  • PTCA percutaneous transluminal coronary recanalization
  • a catheter is inserted through a puncture into the skin into a blood vessel and advanced over the blood vessel until, for example, an arteriosclerotic narrowing in the coronary arteries.
  • a refillable balloon is attached to the end of the catheter. This balloon is pressurized and the constriction in the blood vessel is expanded by this pressure. The balloon can then be deflated and the catheter removed from the body. In the majority of cases, the blood vessel remains open for blood flow.
  • a major complication with this technique is that parts of the intima, the innermost layer of the vessel wall, separate from the vessel wall as a result of this measure detach and then more or less hinder the flow in the vessel.
  • the detached vessel wall can act like a valve flap that completely blocks the flow.
  • this complication also prevents the desired success of the treatment in other treatment locations and if the complication is less unfavorable.
  • the stents known from US Pat. No. 4,655,771 have been inserted into the vessel at the treated site in order to keep the vessel open from the inside.
  • a catheter is inserted into the blood vessel through the same puncture that has already been used for the balloon catheter.
  • the stent is located inside this catheter at its distal end, which is distant from the operator.
  • the stent is cylindrical and consists of a network of crossing stiff threads. It is of the self-expanding type, i.e. it is inserted into the catheter in a tensioned state and relaxes without help on its own.
  • Other types of stent must e.g. brought into their expanded state by an internal balloon.
  • the stent is released by withdrawing the outer catheter from the catheter and detached from the catheter.
  • a displaceable inner catheter lying in the catheter serves as an abutment for as long as the outer catheter is withdrawn.
  • the vascular support remains in the vessel after its release, it supports the vessel permanently. The catheter, however, is withdrawn as usual and the puncture site in the vessel is closed.
  • vascular supports serve their purpose in that they press the detached innermost vascular layer, the intima, against the vessel wall and thus keep the vessel open for flow. Difficulties arise, however, in that these stents can cause blood clots. This danger must be countered with high, potentially dangerous doses of anticoagulant drugs. After a few weeks, the vascular support is overgrown by the inner lining of the vessel, the endothelium, and the risk of blood clots is largely eliminated. Now a new difficulty arises. It turns out that the tissue cells that were stimulated to grow by the insertion of the stent do not stop growing in some cases. The vessel can therefore be partially or completely closed again.
  • a detached intima can be reconnected to the vessel wall and healed in a relatively short time.
  • the healing times are extended by anticoagulant drugs that may be necessary during treatment.
  • catheters have already been proposed in which the stent supports the vessel wall only temporarily and can then be removed from the vessel again.
  • EP 0 321 912 A1 It is a stent made of a mesh tube made of interwoven wires, which is inserted into the vessel in a stretched manner. At the treatment site, the two ends of the net tube are moved against each other, and the net between the ends bulges out into a hollow shape that lies against the inner wall of the vessel and supports it.
  • the network from which the stent graft is made is not self-expanding in this case, but has its relaxed position in the stretched state. In this relaxed, stretched state with a small circumference, the stent is inserted into the vessel introduced and removed from the vessel after use.
  • a disadvantage of this design is that the individual wires can kink if the ends of the network tube are pulled too much against one another and the wires in the vessel cannot deflect. With kinked wires, the catheter can only be removed from the vessel with complications because the actuating elements of the net can only transmit compressive forces to a limited extent in order to bring the net back into the elongated shape with a small circumference.
  • Another disadvantage is that the net is bundled together at its two ends, so the mesh must be passed through twice by the flowing blood when it is used in the blood vessel, at the front end of the stent and at the rear end of the stent.
  • Another disadvantage is that the actuating forces for keeping the net tube open must be maintained over a relatively long distance from the outside during the treatment period. Transmission errors can occur if, for example, the catheter is moved between the skin puncture and the treatment site.
  • a stent that can be removed from the body is shown in WO 91/07928.
  • the stent is formed from a single, helically wound wire.
  • the wire is stretched and received in a thin catheter tube and is pushed out of it.
  • the individual turns of the screw form push radially outwards and support the vessel wall.
  • the wire is pulled back into the catheter to remove the stent.
  • the wire then resumes its elongated shape.
  • This stent is therefore of the self-expanding type.
  • the helical stent does not remain stationary when it is inserted and removed from the stent.
  • the relaxed part of the coil spring must rotate relative to the wire in the catheter to compensate for the different condition of the wire.
  • the free rotating end of the wire in the wall of the vessel can cause injuries.
  • the helical stent can move under a detached flap of the vessel wall and thus prevent it from fulfilling its task.
  • This stent is therefore not effective, such as the well-known stent permanently remaining in the vessel. Difficulties are also caused by the high frictional forces of the tensioned wire in the thin catheter. To eject the stent from the catheter, great resistances must be overcome, which even increase when the wire is pressed against the catheter wall during ejection.
  • a stent that can be removed from the vessel is published in EP 0 423 916 A1. It is a scissor grid made of a stainless steel wire in the form of a piece of tubular casing. This stent is also of the self-expanding type and, like the stent according to US Pat. No. 4,655,771, is retracted External catheter inserted into the vessel compared to an inner catheter. A thread is attached to the proximal edge of the scissor grid, which is close to the operator and which is assembled to form a piece of hose casing, at the edge of the hose casing. With this thread, the tubular jacket can be tied up at its proximal end.
  • both ends of this thread are passed outside the body and loosely secured there as long as the stent is in the vessel. If the stent is to be removed, a new catheter is advanced to the stent over these two threads and the proximal end of the support is tied up by pulling on the threads. A second, correspondingly larger catheter is then pushed over the first. The stent is now pulled together with the threads until it fits into the larger catheter and can be pulled into it. Then both catheters are removed together with the stent.
  • the advantage of this arrangement is the good flow that results when the stent is inserted, because the tube jacket piece is open at both ends.
  • a disadvantage is the great effort that must be driven for this arrangement.
  • the invention has therefore set itself the task of a catheter with a self-contained and when Free to develop non-twisting stent so that the stent can be reliably removed from the vessel without difficulty after a temporary period of use, whereby the stent to be further developed should be of the self-expanding type in order to ensure that the removable stent can be operated without risk, whereby the The catheter should be as simple as possible and should be simple and easy to use, and the flow of the medium should be prevented as little as possible during the temporary use of the stent in the vessel. At the same time, a method for producing this catheter is to be specified.
  • the stent is secured at its proximal end in such a way that it forms a permeable mesh cone that opens itself with the stent, the radius of which slowly increases to the radius of the relaxed stent and that the stent is firmly attached to it using the mesh cone Inner catheter is anchored.
  • the outer catheter shaft can be pushed smoothly over the stent from the start, or the stent can be pulled back smoothly into the catheter.
  • the contracting forces are due to the shape of the mesh cone large enough, but also so evenly distributed that the stent can be brought back to the originally taken small size and fit again in the same outer catheter shaft originally used.
  • the catheter can then be pulled off with the stent.
  • the elements of the operating sequence are extremely simple and are also known from the conventional permanent stent.
  • the use of the permeable mesh cone as a fastening means for the stent on the inner catheter ensures that the flow of the medium in the vessel is hampered as little as possible.
  • the result is a particularly simple and easy-to-manufacture catheter with a smooth transition from the inner catheter to the tip of the mesh cone.
  • the inner catheter is tubular and ends within the stent.
  • the tubular inner catheter can, for example, receive a guide wire so that the stent can be advanced along a guide wire already placed in the body.
  • the catheter can also use a method for removing blood clots described in DE GM 89 10 603.2, in addition to the use of a stent that can be removed again Arteries and veins can be inserted using a Fogarty catheter.
  • the inner catheter does not receive a guide wire, but a balloon catheter, the Fogarthy catheter. This balloon catheter can then in turn optionally be equipped with an inner guide wire.
  • the balloon of this Fogarty catheter is elastic, ie it can largely adapt to the vessel diameter.
  • the Fogarty catheter is advanced out of the inner catheter through the blood vessel and pushed through a blood clot located in the blood vessel.
  • the balloon of the Fogarty catheter is inflated behind the blood clot and the Fogarty catheter is withdrawn.
  • the inflated balloon pushes the blood clot in front of it in the blood vessel until the blood clot is caught between the balloon and the catheter according to the invention.
  • DE GM 89 10 603.2 the distal end of the stent must now be used as a collecting basket.
  • the stent is advanced until its distal end has emerged from the outer catheter shaft and has expanded to the diameter of the vessel.
  • the collecting basket, or the stent used as the collecting basket, is then drawn back into the outer catheter shaft of the catheter according to the invention.
  • the grass collector contracts again, squeezes out the blood clot and separates liquid components from fibrous components.
  • the stent serving as a collecting basket together with the fibrous components of the blood clot is resumed by the outer catheter shaft.
  • the blood clot can now be removed together with the catheter.
  • DE GM 89 10 603.2 it was considered advantageous to cover the grass catcher with an impermeable coating or membrane the blood clot does not escape from the collecting basket.
  • the meshes which become smaller towards the catheter shaft in the stent of the catheter according to the invention are sufficient to retain the fibrous components of the blood clot and that the catheter according to the invention can therefore also be used for the method according to DE GM 89 10 603.2.
  • the specified measure thus creates a multi-purpose instrument that can be used on the one hand as a removable stent, but on the other hand as a device for removing blood clots from arteries and veins.
  • the outer catheter shaft in the stated multi-purpose instrument can also be provided with a protective cap that can be pierced by the stent.
  • the catheter is no longer completely open at the front when it is pushed through the vessel. Above all, injuries to the vessel wall through the front edge of the outer catheter shaft are avoided. Despite this protection when advancing, the stent can be released at the treatment site, since the protective cap can be pierced by the stent.
  • a particularly advantageous method for producing a catheter according to the invention results if the tip of the mesh cone of the stent is held together by a shrink tube on the outside diameter of the inner catheter while the mesh cone is connected to the inner catheter.
  • the network of the stent is clamped evenly from all sides by a simple measure, and the connection can be established undisturbed by heat treatment or with the aid of binders.
  • a particular advantage of this method is that the clamping exerts a constant force, even if the clamped object yields or even becomes smaller in diameter. This peculiarity of the proposed method is important when the connection is made by heat treatment, but also when connected to Binder the smallest possible diameter of the finished connection is to be achieved.
  • Fig. 1, 1 is idealized, e.g. of a human body.
  • the vessel can contain liquids, e.g. Collect blood, but it can also carry air, so that the vessel can also represent a trachea.
  • the distal end of a catheter 2, remote from the operator, is shown lying in this vessel.
  • the catheter 2 is at a suitable location, e.g. at a puncture, has been inserted into the vessel and has been advanced from outside the body to the point shown in the vessel.
  • the catheter 2 consists of a tubular outer catheter shaft 3 and an inner catheter 4 which is displaceable therein. In the position shown in FIG. 1, the inner catheter 4 is pushed out a little from the distal end of the outer catheter shaft 3.
  • a stent 5 in the vessel 1.
  • the stent 5 is made from a permeable network of stiff threads 6 which intersect.
  • the stiffness of the threads 6 is selected such that the stent 5, when used, is characterized by its radial elasticity from a tense state with a small circumference own strength expands into a relaxed state supporting the wall of the vessel with a large circumference that remains the same over the length.
  • a part of the stent 5 can be seen in the tensioned state in FIG. 2.
  • the tensioned part of the stent 5 is contracted in the left half of the figure to a small extent, trapped at the distal end in the tubular outer catheter shaft 3.
  • the outer catheter shaft 3 In order to release the stent 5 for its use in its relaxed state, in which it expands in a self-expanding manner, lies against the vessel wall and supports it, the outer catheter shaft 3 must be withdrawn with respect to the inner catheter 4.
  • the inner catheter 4 must axially support the stent 5 in the outer catheter shaft 3 on the inner wall so that a relative movement between the outer catheter shaft 3 and stent 5 can occur.
  • the stent 5 is open at its distal end, so that the medium can flow freely through the stent 1. It can be seen in particular in FIG. 1 that the stent, however, is secured at its proximal, user-friendly end so that it forms a permeable mesh cone 7.
  • the mesh cone 7 is made from the same stiff threads 6 as the stent 5, so that it opens together with the stent itself.
  • the radius of this network cone 7 slowly increases to the radius of the stent 5.
  • the mesh cone 7 is contracted to the outer diameter of the inner catheter 4. There it is connected to the inner catheter by a layer of binding agent.
  • the stent 5 is therefore firmly anchored to the inner catheter 4 at the connection point 8 with the aid of the mesh cone 7.
  • An advantageous method of producing a catheter 2 according to the invention is to hold the stent 5 at its proximal end together with a shrink tube on the outside diameter of the inner catheter 4, while the mesh cone 7 is connected to the inner catheter 4.
  • the shrink tube is in its raw state in which it still has a large diameter, pulled over the stent 5.
  • the shrink tube is then heated, it contracts and thereby also constricts the stent 5, which it surrounds.
  • Dimensions and material of the shrink tube as well as the heat supply to the shrink tube can be selected so that the shrink tube pulls the stent 5 to the outside diameter of the inner catheter 4 and holds it there.
  • the stent 5 can then be welded to the inner catheter 4 or a layer of binder which has been previously applied or which migrates into the connection 8 by capillary action under the shrink tube can harden.
  • the shrink tube can be removed again, so that, as shown in FIGS. 1 and 2, a smooth connection point 8 remains, which, depending on the method selected, can essentially have the diameter of the inner catheter 4.
  • the stent 5 is initially stretched at the distal end inside the outer catheter shaft 3 in the catheter 2.
  • the inner catheter 4 is retracted relative to the outer catheter shaft 3 and the stent 5 lies against the inner wall of the outer catheter shaft 3 as in the left part of FIG. 2.
  • the inner catheter is withdrawn to such an extent that the distal end of the stent 5 lies within the outer catheter shaft 3.
  • the catheter 2 is inserted into the vessel 1 and advanced in this vessel 1.
  • the outer catheter shaft 2 is withdrawn with respect to the inner catheter 4 which is held stationary.
  • the connection of the stent 5 with the stationary inner catheter 4 results in a relative movement between the stent and the outer catheter shaft 3.
  • the stent 5 is slowly released piece by piece, starting from its distal end. It emerges from the distal end of the outer catheter shaft 3 and expands slowly into its relaxed state, in which it lies against the vessel wall and supports it.
  • Fig. 2 shows the state when the outer Catheter shaft 3 is withdrawn approximately half the length. The stent is now released as far as necessary, for example until the connection point 8 has emerged from the distal end of the outer catheter shaft 3, as in FIG. 1.
  • the outer catheter shaft 3 only has to be pushed forward relative to the inner catheter 4.
  • the connection of the stent 5 with the inner catheter 4 also results in a relative movement between the stent and the outer catheter shaft 3.
  • the connection of the stent 5 with the inner catheter 4 with the aid of a mesh cone 7, the tip of which is attached to the inner catheter 4 slides The outside of the catheter shaft 3 along the network of the stent 5 and thereby forces the cone 7 rising from the inner catheter 4 and the adjoining stent 5 back into its taut form in which it can be received again by the catheter shaft 3.
  • the inner catheter 4 can also be withdrawn with respect to the outer catheter shaft 3. In this way, the stent 5 can be fully retracted into the outer catheter shaft 5 and the catheter 2 can be removed from the vessel 1.
  • the inner catheter 4 is also tubular and the inner catheter 4 ends distally behind the connection point 8.
  • the tubular inner catheter 4 receives, for example, a guide wire.
  • This can be a guidewire which is advanced in the body for use of the catheter 2 and which the catheter 2 can then follow. However, it can also be a guide wire that is already in the body from a previous treatment, for example from treatment with a balloon catheter.
  • the inner catheter 4 ends directly behind the connection point 8.
  • the catheter 2 can In this case, in addition to the use of a removable stent 5, it can also be used for a method for removing blood clots from arteries and veins according to DE GM 89 10 603.2, which is described in the introduction. The procedure is described in detail in the introduction and in the specified location, the description will not be repeated here.
  • the inner catheter 4 does not have to end directly behind the connection point 8, it can also end at a distance from the distal end of the stent 5, it is sufficient if it ends in any case within the stent 5.
  • a protective cap 9 is attached to the catheter shaft 3 at the distal end of the outer catheter shaft 3. It is thermally or bonded to the catheter shaft 3, but it can also be formed in one piece from the material of the catheter shaft 3 itself.
  • the protective cap 9 can be deformed elastically or permanently. When the catheter 2 is introduced into the vessel 1, this protective cap 9 is closed. It thus prevents excessive penetration of the liquid from the vessel into the catheter 2.
  • the cap 9 has a rounded tip. By covering the distal edge of the outer catheter shaft 3, the rounding at the tip and by its flexibility, the cap 9 prevents injuries to the vessel wall when the catheter 2 is advanced.
  • the cap 9 When the catheter 2 has arrived at the treatment site, the cap 9 is pierced by the stent 5, which is pushed relative to the outer catheter shaft 3, and thus opened. Slots 10 in the cap 9 can facilitate this process.
  • Fig. 3 the cap 9 is shown in the fully open state, in Fig. 2 the in this case elastic cap 9 is partially closed again, since the diameter that passes through, the inner catheter 4, is smaller than the largest diameter that passes through.
  • the cap 9 closes again if it is an elastic cap 9. Since, when the catheter 2 is withdrawn from the vessel 1, there is no longer any risk that the vessel wall will be damaged by the edge of the catheter shaft 3, the cap 9 can also be designed such that it no longer closes automatically after use of the stent 5, but that the cap 9 remains in the last position taken.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
EP92200294A 1992-02-03 1992-02-03 Cathéter avec un support vasculaire Expired - Lifetime EP0554579B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
EP92200294A EP0554579B1 (fr) 1992-02-03 1992-02-03 Cathéter avec un support vasculaire
AT92200294T ATE135900T1 (de) 1992-02-03 1992-02-03 Katheter mit einer gefässstütze
ES92200294T ES2086633T3 (es) 1992-02-03 1992-02-03 Cateter con un sustentaculo vascular.
DE59205857T DE59205857D1 (de) 1992-02-03 1992-02-03 Katheter mit einer Gefässstütze
CA2088557A CA2088557C (fr) 1992-02-03 1993-02-01 Catheter muni d'un extenseur
AU32185/93A AU654075B2 (en) 1992-02-03 1993-02-02 Catheter with a stent
RU9393005293A RU2055545C1 (ru) 1992-02-03 1993-02-03 Катетер и способ его соединения
JP5016416A JP2620028B2 (ja) 1992-02-03 1993-02-03 カテーテル及びその製造並びに使用方法
US08/433,281 US5607466A (en) 1992-02-03 1995-04-28 Catheter with a stent
US08/752,273 US5725571A (en) 1992-02-03 1996-11-20 Catheter with a stent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200294A EP0554579B1 (fr) 1992-02-03 1992-02-03 Cathéter avec un support vasculaire

Publications (2)

Publication Number Publication Date
EP0554579A1 true EP0554579A1 (fr) 1993-08-11
EP0554579B1 EP0554579B1 (fr) 1996-03-27

Family

ID=8210398

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92200294A Expired - Lifetime EP0554579B1 (fr) 1992-02-03 1992-02-03 Cathéter avec un support vasculaire

Country Status (9)

Country Link
US (2) US5607466A (fr)
EP (1) EP0554579B1 (fr)
JP (1) JP2620028B2 (fr)
AT (1) ATE135900T1 (fr)
AU (1) AU654075B2 (fr)
CA (1) CA2088557C (fr)
DE (1) DE59205857D1 (fr)
ES (1) ES2086633T3 (fr)
RU (1) RU2055545C1 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032078A1 (fr) * 1995-04-14 1996-10-17 Schneider (Usa) Inc. Dispositif d'introduction d'un extenseur a membrane a enroulement
WO1999030763A1 (fr) * 1997-12-18 1999-06-24 Viktor Tomovich Partosh Dispositif servant a mettre en place une endoprothese
WO2000012030A1 (fr) * 1998-08-27 2000-03-09 Scimed Life Systems, Inc. Catheter d'apport d'extenseur a auto-extension
WO2001010345A1 (fr) * 1999-08-05 2001-02-15 Aesculap Ag & Co. Kg Catheter d'insertion pour protheses vasculaires
EP1227771B1 (fr) * 1999-11-11 2007-08-01 Angiomed GmbH & Co. Medizintechnik KG Dispositif de mise en place d'implant
EP2008616A1 (fr) * 2007-06-29 2008-12-31 Olympus Medical Systems Corp. Outil de traitement endoscopique
US7758624B2 (en) 2000-11-13 2010-07-20 C. R. Bard, Inc. Implant delivery device
CN110536716A (zh) * 2017-04-20 2019-12-03 朝日英达科株式会社 导管
US10588636B2 (en) 2017-03-20 2020-03-17 Surefire Medical, Inc. Dynamic reconfigurable microvalve protection device
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
US10806893B2 (en) 2017-01-10 2020-10-20 Surefire Medical, Inc. Guiding catheter having shape-retentive distal end
US10813739B2 (en) 2009-12-02 2020-10-27 Surefire Medical, Inc. Dynamic microvalve protection device
US11090460B2 (en) 2015-03-31 2021-08-17 Surefire Medical, Inc. Method for infusing an immunotherapy agent to a solid tumor for treatment
US11135361B2 (en) 2014-03-25 2021-10-05 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59205857D1 (de) * 1992-02-03 1996-05-02 Schneider Europ Ag Katheter mit einer Gefässstütze
ATE247435T1 (de) * 1992-05-08 2003-09-15 Schneider Usa Inc Stent für den oesophagus
EP0592726B1 (fr) * 1992-10-12 1997-03-05 Schneider (Europe) Ag Cathéter avec un support vasculaire
US5480423A (en) 1993-05-20 1996-01-02 Boston Scientific Corporation Prosthesis delivery
US6994689B1 (en) 1995-06-05 2006-02-07 Medtronic Vascular, Inc. Occlusion of a vessel
US6312407B1 (en) 1995-06-05 2001-11-06 Medtronic Percusurge, Inc. Occlusion of a vessel
EP0836416A1 (fr) 1995-06-06 1998-04-22 Corvita Corporation Appareil de mesure endovasculaire, moyen de chargement et de deploiement
JP2836547B2 (ja) * 1995-10-31 1998-12-14 日本電気株式会社 基準電流回路
ES2131253T3 (es) * 1995-11-14 1999-07-16 Schneider Europ Gmbh Dispositivo para la implantacion de una endoprotesis.
US6270477B1 (en) 1996-05-20 2001-08-07 Percusurge, Inc. Catheter for emboli containment
US6544276B1 (en) * 1996-05-20 2003-04-08 Medtronic Ave. Inc. Exchange method for emboli containment
US5980514A (en) * 1996-07-26 1999-11-09 Target Therapeutics, Inc. Aneurysm closure device assembly
US6096034A (en) * 1996-07-26 2000-08-01 Target Therapeutics, Inc. Aneurysm closure device assembly
US6254628B1 (en) * 1996-12-09 2001-07-03 Micro Therapeutics, Inc. Intracranial stent
US6494904B1 (en) * 1996-12-27 2002-12-17 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
US5957974A (en) 1997-01-23 1999-09-28 Schneider (Usa) Inc Stent graft with braided polymeric sleeve
US5906641A (en) * 1997-05-27 1999-05-25 Schneider (Usa) Inc Bifurcated stent graft
CA2424551A1 (fr) * 1997-05-27 1998-11-27 Schneider (Usa) Inc. Tuteur et endoprothese pour le traitement de vaisseaux sanguins ramifie
DE69732229T2 (de) * 1997-07-17 2005-12-29 Schneider (Europe) Gmbh Stent sowie Herstellungsverfahren dafür
EP0917886B1 (fr) * 1997-10-23 2003-10-01 Schneider (Europe) GmbH Joint pour assemblage de cathéter avec ballonnets d'occlusion et dilatation
US6533807B2 (en) 1998-02-05 2003-03-18 Medtronic, Inc. Radially-expandable stent and delivery system
US6338709B1 (en) 1998-02-19 2002-01-15 Medtronic Percusurge, Inc. Intravascular radiation therapy device and method of use
US6520983B1 (en) * 1998-03-31 2003-02-18 Scimed Life Systems, Inc. Stent delivery system
US6264689B1 (en) 1998-03-31 2001-07-24 Scimed Life Systems, Incorporated Low profile medical stent
US6217609B1 (en) 1998-06-30 2001-04-17 Schneider (Usa) Inc Implantable endoprosthesis with patterned terminated ends and methods for making same
US6231588B1 (en) 1998-08-04 2001-05-15 Percusurge, Inc. Low profile catheter for angioplasty and occlusion
US6093194A (en) 1998-09-14 2000-07-25 Endocare, Inc. Insertion device for stents and methods for use
US6162231A (en) * 1998-09-14 2000-12-19 Endocare, Inc. Stent insertion device
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6458139B1 (en) 1999-06-21 2002-10-01 Endovascular Technologies, Inc. Filter/emboli extractor for use in variable sized blood vessels
US6146404A (en) * 1999-09-03 2000-11-14 Scimed Life Systems, Inc. Removable thrombus filter
US6458151B1 (en) * 1999-09-10 2002-10-01 Frank S. Saltiel Ostial stent positioning device and method
US6368344B1 (en) 1999-12-16 2002-04-09 Advanced Cardiovascular Systems, Inc. Stent deployment system with reinforced inner member
US6514273B1 (en) 2000-03-22 2003-02-04 Endovascular Technologies, Inc. Device for removal of thrombus through physiological adhesion
US20020016597A1 (en) * 2000-08-02 2002-02-07 Dwyer Clifford J. Delivery apparatus for a self-expanding stent
US6773446B1 (en) 2000-08-02 2004-08-10 Cordis Corporation Delivery apparatus for a self-expanding stent
US6673106B2 (en) * 2001-06-14 2004-01-06 Cordis Neurovascular, Inc. Intravascular stent device
US20030135269A1 (en) * 2002-01-16 2003-07-17 Swanstrom Lee L. Laparoscopic-assisted endovascular/endoluminal graft placement
US7169170B2 (en) 2002-02-22 2007-01-30 Cordis Corporation Self-expanding stent delivery system
US6989024B2 (en) * 2002-02-28 2006-01-24 Counter Clockwise, Inc. Guidewire loaded stent for delivery through a catheter
US6866679B2 (en) 2002-03-12 2005-03-15 Ev3 Inc. Everting stent and stent delivery system
US7195648B2 (en) * 2002-05-16 2007-03-27 Cordis Neurovascular, Inc. Intravascular stent device
US7335218B2 (en) 2002-08-28 2008-02-26 Heart Leaflet Technologies, Inc. Delivery device for leaflet valve
US7264631B2 (en) * 2002-09-16 2007-09-04 Scimed Life Systems, Inc. Devices and methods for AAA management
US20080033570A1 (en) * 2003-08-01 2008-02-07 Blitz Benjamin T Prostatic stent placement device
WO2005013855A2 (fr) * 2003-08-01 2005-02-17 Cook Urological, Incorporated Dispositif de mise en place d'un implant
US9254213B2 (en) * 2004-01-09 2016-02-09 Rubicon Medical, Inc. Stent delivery device
US8998973B2 (en) * 2004-03-02 2015-04-07 Boston Scientific Scimed, Inc. Medical devices including metallic films
US7901447B2 (en) * 2004-12-29 2011-03-08 Boston Scientific Scimed, Inc. Medical devices including a metallic film and at least one filament
US8992592B2 (en) * 2004-12-29 2015-03-31 Boston Scientific Scimed, Inc. Medical devices including metallic films
US8632580B2 (en) * 2004-12-29 2014-01-21 Boston Scientific Scimed, Inc. Flexible medical devices including metallic films
US20050197687A1 (en) * 2004-03-02 2005-09-08 Masoud Molaei Medical devices including metallic films and methods for making same
US8591568B2 (en) * 2004-03-02 2013-11-26 Boston Scientific Scimed, Inc. Medical devices including metallic films and methods for making same
US20060142838A1 (en) * 2004-12-29 2006-06-29 Masoud Molaei Medical devices including metallic films and methods for loading and deploying same
US8617234B2 (en) * 2004-05-25 2013-12-31 Covidien Lp Flexible vascular occluding device
US8623067B2 (en) 2004-05-25 2014-01-07 Covidien Lp Methods and apparatus for luminal stenting
EP2626038B1 (fr) 2004-05-25 2016-09-14 Covidien LP Dispositif d'occlusion vasculaire souple
EP2419048A4 (fr) 2004-05-25 2014-04-09 Covidien Lp Implantation d'endoprothèses vasculaires pour l'anévrysme
US20060206200A1 (en) * 2004-05-25 2006-09-14 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US8267985B2 (en) 2005-05-25 2012-09-18 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
US7303580B2 (en) * 2004-07-26 2007-12-04 Cook Incorporated Stent delivery system allowing controlled release of a stent
US20060253184A1 (en) * 2005-05-04 2006-11-09 Kurt Amplatz System for the controlled delivery of stents and grafts
US20070118207A1 (en) * 2005-05-04 2007-05-24 Aga Medical Corporation System for controlled delivery of stents and grafts
US8652193B2 (en) 2005-05-09 2014-02-18 Angiomed Gmbh & Co. Medizintechnik Kg Implant delivery device
US7854760B2 (en) * 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
EP1883371B1 (fr) 2005-05-25 2015-10-07 Covidien LP Systeme et procede destines a distribuer et deployer un dispositif d'occlusion a l'interieur d'un vaisseau
US8273101B2 (en) 2005-05-25 2012-09-25 Tyco Healthcare Group Lp System and method for delivering and deploying an occluding device within a vessel
WO2007095031A2 (fr) * 2006-02-13 2007-08-23 Bay Street Medical, Inc. Systeme pour poser un stent
WO2007100556A1 (fr) 2006-02-22 2007-09-07 Ev3 Inc. Systemes de protection embolique munis d'un tamis filtrant radio-opaque
US8652192B2 (en) * 2006-03-31 2014-02-18 St. Jude Medical, Cardiology Division, Inc. Stent and system and method for deploying a stent
EP2068764A4 (fr) * 2006-09-28 2016-07-27 Heart Leaflet Technologies Inc Outil d'installation pour installation percutanée d'une prothèse
KR101659197B1 (ko) 2006-10-22 2016-09-22 이데브 테크놀로지스, 아이엔씨. 스텐트 전진을 위한 장치 및 방법
CN102525700B (zh) 2006-10-22 2015-05-13 Idev科技公司 支架推进装置
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
US20080255654A1 (en) * 2007-03-22 2008-10-16 Bay Street Medical System for delivering a stent
US20080300667A1 (en) * 2007-05-31 2008-12-04 Bay Street Medical System for delivering a stent
US9144508B2 (en) * 2007-07-19 2015-09-29 Back Bay Medical Inc. Radially expandable stent
EP2254527A1 (fr) * 2008-03-27 2010-12-01 NFocus Neuromedical, Inc. Système de mise en place d implant à verrouillage distal par frottement et ses composants
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US20090319019A1 (en) * 2008-06-23 2009-12-24 Cook Incorporated Expandable Tip Delivery System For Endoluminal Prosthesis
US20100191168A1 (en) 2009-01-29 2010-07-29 Trustees Of Tufts College Endovascular cerebrospinal fluid shunt
WO2011127392A2 (fr) 2010-04-08 2011-10-13 BiO2 Medical, Inc. Embout de cathéter
US8398610B2 (en) * 2010-04-13 2013-03-19 Medtronic Vascular, Inc. Catheter with distensible and frangible cap
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
US9724223B2 (en) 2011-05-27 2017-08-08 Abbotcardiovascular Systems Inc. Delivery system for a self expanding stent
US20130226278A1 (en) 2012-02-23 2013-08-29 Tyco Healthcare Group Lp Methods and apparatus for luminal stenting
US9072624B2 (en) 2012-02-23 2015-07-07 Covidien Lp Luminal stenting
US9078659B2 (en) 2012-04-23 2015-07-14 Covidien Lp Delivery system with hooks for resheathability
GB2503657B (en) 2012-06-29 2014-05-14 Cook Medical Technologies Llc Introducer assembly and sheath therefor
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9724222B2 (en) * 2012-07-20 2017-08-08 Covidien Lp Resheathable stent delivery system
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
CN103007423B (zh) * 2012-12-18 2014-10-29 曾晨光 负压吸引器
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
CN103271785A (zh) * 2013-06-08 2013-09-04 周玉杰 锥形金属支架
US10130500B2 (en) 2013-07-25 2018-11-20 Covidien Lp Methods and apparatus for luminal stenting
US8968383B1 (en) 2013-08-27 2015-03-03 Covidien Lp Delivery of medical devices
US9782186B2 (en) 2013-08-27 2017-10-10 Covidien Lp Vascular intervention system
US9737696B2 (en) 2014-01-15 2017-08-22 Tufts Medical Center, Inc. Endovascular cerebrospinal fluid shunt
WO2015108917A1 (fr) 2014-01-15 2015-07-23 Tufts Medical Center, Inc. Dérivation de liquide cérébro-spinal endovasculaire
US9855156B2 (en) * 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
CN107148293B (zh) 2014-10-31 2020-08-11 西瑞维斯克有限责任公司 用于治疗脑积水的方法和系统
US10639181B2 (en) 2014-11-04 2020-05-05 Abbott Cardiovascular Systems Inc. Methods and systems for delivering an implant
US10433994B2 (en) 2014-11-04 2019-10-08 Abbott Cardiovascular Systems Inc. Methods and systems for delivering an implant
US9682216B2 (en) 2014-12-05 2017-06-20 Anchor Endovascular, Inc. Anchor device for use with catheters
WO2017075544A1 (fr) 2015-10-30 2017-05-04 Cerevasc, Llc Systèmes et procédés de traitement de l'hydrocéphalie
RU2639858C2 (ru) * 2015-12-09 2017-12-22 Общество с ограниченной ответственностью "СП-Сфера" Устройство для выполнения реканализации окклюзированного сосуда (варианты)
EP3457985B1 (fr) 2016-05-16 2021-02-17 Elixir Medical Corporation Libération de stent
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
EP3481342B1 (fr) 2016-09-19 2020-04-29 CTI Vascular AG Système de cathéter pour le traitement de maladies vasculaires et non vasculaires
US10376396B2 (en) 2017-01-19 2019-08-13 Covidien Lp Coupling units for medical device delivery systems
US11771875B2 (en) 2017-03-02 2023-10-03 CereVasc, Inc. Catheter systems and methods for medical procedures using catheters
CN106691627A (zh) * 2017-03-08 2017-05-24 湖南埃普特医疗器械有限公司 一种腔内临时性的支撑装置
US11013900B2 (en) 2018-03-08 2021-05-25 CereVasc, Inc. Systems and methods for minimally invasive drug delivery to a subarachnoid space
US10786377B2 (en) 2018-04-12 2020-09-29 Covidien Lp Medical device delivery
US11071637B2 (en) 2018-04-12 2021-07-27 Covidien Lp Medical device delivery
US11413176B2 (en) 2018-04-12 2022-08-16 Covidien Lp Medical device delivery
US11123209B2 (en) 2018-04-12 2021-09-21 Covidien Lp Medical device delivery
US11413174B2 (en) 2019-06-26 2022-08-16 Covidien Lp Core assembly for medical device delivery systems
EP3785616B1 (fr) * 2019-09-02 2022-12-07 BIOTRONIK SE & Co. KG Cathéter d'implantation
CN113230479B (zh) * 2021-04-22 2022-09-23 西南医科大学附属中医医院 一种膀胱血凝块冲洗器
US11944558B2 (en) 2021-08-05 2024-04-02 Covidien Lp Medical device delivery devices, systems, and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572186A (en) * 1983-12-07 1986-02-25 Cordis Corporation Vessel dilation
FR2624747A1 (fr) * 1987-12-18 1989-06-23 Delsanti Gerard Dispositifs endo-arteriels amovibles destines a reparer des decollements de parois des arteres
US4921484A (en) * 1988-07-25 1990-05-01 Cordis Corporation Mesh balloon catheter device
EP0408245B1 (fr) * 1989-07-13 1994-03-02 American Medical Systems, Inc. Dispositif d'introduction d'un dilatateur
DE8910603U1 (fr) * 1989-09-06 1989-12-07 Guenther, Rolf W., Prof. Dr.
US5002560A (en) * 1989-09-08 1991-03-26 Advanced Cardiovascular Systems, Inc. Expandable cage catheter with a rotatable guide
US5180368A (en) * 1989-09-08 1993-01-19 Advanced Cardiovascular Systems, Inc. Rapidly exchangeable and expandable cage catheter for repairing damaged blood vessels
US5034001A (en) * 1989-09-08 1991-07-23 Advanced Cardiovascular Systems, Inc. Method of repairing a damaged blood vessel with an expandable cage catheter
US5035706A (en) * 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
GB2238245B (en) * 1989-11-24 1994-04-20 Martin Terry Rothman Catheters
US5082359A (en) * 1989-11-28 1992-01-21 Epion Corporation Diamond films and method of growing diamond films on nondiamond substrates
US5053014A (en) * 1990-02-01 1991-10-01 Critikon, Inc. Catheter with controlled valve
DE59205857D1 (de) * 1992-02-03 1996-05-02 Schneider Europ Ag Katheter mit einer Gefässstütze

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US5071407A (en) * 1990-04-12 1991-12-10 Schneider (U.S.A.) Inc. Radially expandable fixation member

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032078A1 (fr) * 1995-04-14 1996-10-17 Schneider (Usa) Inc. Dispositif d'introduction d'un extenseur a membrane a enroulement
US5662703A (en) * 1995-04-14 1997-09-02 Schneider (Usa) Inc. Rolling membrane stent delivery device
WO1999030763A1 (fr) * 1997-12-18 1999-06-24 Viktor Tomovich Partosh Dispositif servant a mettre en place une endoprothese
WO2000012030A1 (fr) * 1998-08-27 2000-03-09 Scimed Life Systems, Inc. Catheter d'apport d'extenseur a auto-extension
US6120522A (en) * 1998-08-27 2000-09-19 Scimed Life Systems, Inc. Self-expanding stent delivery catheter
WO2001010345A1 (fr) * 1999-08-05 2001-02-15 Aesculap Ag & Co. Kg Catheter d'insertion pour protheses vasculaires
US6887267B2 (en) 1999-08-05 2005-05-03 Aesculap Ag & Co. Kg Insertion catheter for vascular prosthesis
US8092509B2 (en) 1999-11-11 2012-01-10 Angiomed Gmbh & Co. Medizintechnik Kg Implant delivery device
EP1227771B1 (fr) * 1999-11-11 2007-08-01 Angiomed GmbH & Co. Medizintechnik KG Dispositif de mise en place d'implant
US7758624B2 (en) 2000-11-13 2010-07-20 C. R. Bard, Inc. Implant delivery device
US8790390B2 (en) 2007-06-29 2014-07-29 Olympus Medical Systems Corp. Endoscope treatment tool
EP2008616A1 (fr) * 2007-06-29 2008-12-31 Olympus Medical Systems Corp. Outil de traitement endoscopique
US10813739B2 (en) 2009-12-02 2020-10-27 Surefire Medical, Inc. Dynamic microvalve protection device
US11135361B2 (en) 2014-03-25 2021-10-05 Surefire Medical, Inc. Closed tip dynamic microvalve protection device
US11090460B2 (en) 2015-03-31 2021-08-17 Surefire Medical, Inc. Method for infusing an immunotherapy agent to a solid tumor for treatment
US10780250B1 (en) 2016-09-19 2020-09-22 Surefire Medical, Inc. System and method for selective pressure-controlled therapeutic delivery
US11400263B1 (en) 2016-09-19 2022-08-02 Trisalus Life Sciences, Inc. System and method for selective pressure-controlled therapeutic delivery
US10806893B2 (en) 2017-01-10 2020-10-20 Surefire Medical, Inc. Guiding catheter having shape-retentive distal end
US10588636B2 (en) 2017-03-20 2020-03-17 Surefire Medical, Inc. Dynamic reconfigurable microvalve protection device
CN110536716A (zh) * 2017-04-20 2019-12-03 朝日英达科株式会社 导管
US11850398B2 (en) 2018-08-01 2023-12-26 Trisalus Life Sciences, Inc. Systems and methods for pressure-facilitated therapeutic agent delivery
US11338117B2 (en) 2018-10-08 2022-05-24 Trisalus Life Sciences, Inc. Implantable dual pathway therapeutic agent delivery port

Also Published As

Publication number Publication date
RU2055545C1 (ru) 1996-03-10
JPH05253306A (ja) 1993-10-05
JP2620028B2 (ja) 1997-06-11
AU3218593A (en) 1993-08-19
ATE135900T1 (de) 1996-04-15
AU654075B2 (en) 1994-10-20
ES2086633T3 (es) 1996-07-01
US5607466A (en) 1997-03-04
US5725571A (en) 1998-03-10
EP0554579B1 (fr) 1996-03-27
DE59205857D1 (de) 1996-05-02
CA2088557A1 (fr) 1993-08-04
CA2088557C (fr) 1996-03-12

Similar Documents

Publication Publication Date Title
EP0554579B1 (fr) Cathéter avec un support vasculaire
EP0592726B1 (fr) Cathéter avec un support vasculaire
DE60212340T2 (de) Führungsdrahtvorrichtung zur vollständigen okklusion
DE69817146T2 (de) Blutgefässfilter
DE60214973T3 (de) Gerät zur implantierung eines stents mit flüssigkeitsabgabe
DE69533730T2 (de) Schnellaustausch-zuführungskatheter-system
DE69828634T2 (de) Führungsdraht für temporären blutfilter
DE60205053T2 (de) Zeitweiliger intraluminaler Filterführungsdraht und Verfahren zu seiner Verwendung
DE60037339T2 (de) Verfahren zum zusammenbau eines stentkatheters
DE60213352T2 (de) Vorrichtung für einen temporären intraluminalen Schutz
EP1893272B1 (fr) Auxiliaire d'introduction destiné à une trachéostomie percutanée
EP0536610B1 (fr) Dispositif pour la dilatation d'une sténose
DE60119142T2 (de) Endoluminal angebrachtes vaskulares transplant
DE69925627T2 (de) Minimal-invasiver revaskularisationsapparat
DE69434819T2 (de) Einsetzen einer prothese
DE60115239T2 (de) Vorrichtung zum einbringen eines stents
DE69924100T2 (de) Vorrichtung zum reversiblen einbringen einer endoprothese
DE102009052002B4 (de) Medizinische Vorrichtung zum Rekanalisieren von Körperhohlräumen und Set umfassend eine derartige Vorrichtung
DE19828415B4 (de) Stent für ein Endoskop und System zum Einführen dieses Stents
DE102005052226B4 (de) Stent zum Einführen in menschliche Körperhöhlen, insbesondere in Blutgefäße
EP1336392A1 (fr) Support de vaisseau corporel et système de cathéter
CH682978A5 (de) Vorrichtung zum Ausbringen von Blutgerinnseln aus Arterien und Venen.
EP0292587A1 (fr) Cathéter pour créer ou élargir des liaisons vers ou entre les cavités corporelles
EP1303231B1 (fr) Dispositif d'ancrage vasculaire
EP0630617A1 (fr) Dispositif formant sonde d'aspiration

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920214

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB IT LI NL SE

17Q First examination report despatched

Effective date: 19950306

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB IT LI NL SE

REF Corresponds to:

Ref document number: 135900

Country of ref document: AT

Date of ref document: 19960415

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: A. MISRACHI

REF Corresponds to:

Ref document number: 59205857

Country of ref document: DE

Date of ref document: 19960502

ET Fr: translation filed
GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 19960419

ITF It: translation for a ep patent filed

Owner name: STUDIO APRA' BREVETTI

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2086633

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19990118

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19990129

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 19990205

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 19990208

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19990218

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000204

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000229

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20000229

BERE Be: lapsed

Owner name: SCHNEIDER (EUROPE) A.G.

Effective date: 20000228

EUG Se: european patent has lapsed

Ref document number: 92200294.4

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20011010

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20040107

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20040112

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20040202

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20040227

Year of fee payment: 13

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050203

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050901

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050901

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20050203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20051031

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20050901

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20051031